UK Spinout Equity Fell to a Decade Low. For Software Founders, It Did Not Fall Far Enough.

Faraz Rizvi × Foundry · 10 June 2026 · 10 min read · Markdown

Faraz Rizvi is a UK operator-practitioner writing about the work between a research breakthrough and a fundable company. He runs SpinUp Forge. Foundry is SpinUp Forge's custom agentic harness.

UK university founding equity fell to 16% in 2024 — a decade low — and the reform lobby called it proof that the system is working (RAEng, Spotlight on Spinouts 2026). For a software founder, the decade-low headline describes a stake still larger than your company's capital needs justify. The very fact that it is a record low is why no one is looking harder at it.

The figure is a measured market outcome, not a policy target. The Royal Academy of Engineering (RAEng) compiled it from Dealroom data across more than 2,000 UK spinouts formed since 2010 and published it in the first week of June 2026. It is what actually happened.

The reaction was predictable. The convergence narrative — that post-reform university equity would settle into the bands the 2023 Independent Review and TenU guidance recommended — now has hard data behind it. The system is working.

For life sciences, it is. For software, it is not.

The convergence that is not converging

Life sciences equity has reached the recommended bands. Software is still outside them — and the published data now makes that gap visible in numbers, not anecdote.

Is the reform actually reaching software spinouts? No. Software spinouts sit at approximately 17% average university equity — above the sector-wide average, and well above the ceiling TenU recommended two years ago.

TenU — the consortium of ten leading UK research universities — published the USIT for Software framework in May 2024 at Mansion House, co-authored by Cambridge, Edinburgh, Imperial, Manchester, Oxford, and UCL, with VC co-authors including IQ Capital, Cambridge Innovation Capital, Octopus Ventures, and Oxford Science Enterprises (TenU, USIT for Software). The recommendation was 5–10% university equity for software spinouts. The measured outcome, two years later, is 17%.

The gap between 10% and 17% is not seven percentage points of dilution. It is a structural mismatch between what the term sheet prices and what a software company's value-creation model actually requires. (Life-sciences exit data and the survival-rate correlation are in the Evidence note below.)

Why the gap persists

Technology transfer offices apply a single equity model to fundamentally different value-creation structures. The software case for different terms is now in the published data — not just in founder opinion.

Here is the structural reason the gap persists: most technology transfer offices (TTOs — the units inside universities that turn research into licences and companies) do not run separate equity models for software and non-software spinouts. The negotiation defaults to the institutional template, a template designed around life-sciences IP protection timelines, assignment complexity, and the capital structures that characterise regulated-product development.

TenU named the underlying logic: "Software businesses evolve through relentless engagement with customers, understanding their new needs and spotting where the technical advantages of the software can deliver some distinctive performance. This different distribution of value between founding IP and accumulated founder-customer interaction contributes to the justification for different founding equity stake" (TenU, USIT for Software).

In a life-sciences spinout, the university's IP — patent families, licence schedules, regulatory data packages — is load-bearing through to exit. In a software spinout, the IP is typically the starting condition, not the compounding asset. By month twelve, the software itself has usually diverged from the original research contribution enough that the founding IP is historical context, not active competitive advantage. The compounding asset is the product the founders build on top of it, the customer relationships they develop, and the operational cadence they establish.

When a software founder meets the life-sciences template, the result is predictable: an equity stake calibrated to a value-creation model the company will not follow. The RAEng's outcome data confirms the pattern: lower-equity spinouts survive and exit at higher rates — spinouts with university stakes below 15% had a survival rate of 85.5%, compared to 76.4% for those with stakes above 40% (the chart below; RAEng Enterprise Hub, "Mapping equity to outcomes"). The causal direction is debatable — lower stakes may attract stronger founders, or stronger founders may negotiate lower stakes — but the correlation is now measured, not assumed.

David Woolley at the University of Southampton named the institutional logic from the other side: when Southampton reduced its standard equity from 33% to 10%, the reasoning was that the old terms produced too few spinouts (Global University Venturing, "UK universities spinout equity stakes"). That is a volume argument, but it is also an outcome argument. The TTO market has not yet internalised it for software specifically — but the data is now public for the conversation.

What seven percentage points actually costs

The cost is not the dilution itself. It is the speed the dilution consumes — and software founders are the ones for whom speed matters most.

Seven extra percentage points of university equity is not primarily a dilution problem for a pre-seed software spinout. It is a speed problem.

Kerry Baldwin of IQ Capital, contributing to the USIT for Software guide, named speed as the structurally relevant variable: "Speed… matters greatly. The faster a minimum viable product can be tested and launched, the faster product can go to market" (TenU, USIT for Software). Ian Lane of Cambridge Innovation Capital named the investor-side consequence: "Investors hate uncertainty… If it is uncertain whether a university will take 2% or 40%, it is hard" to commit at the speed the market requires. The TenU framework recommended deal finalisation within three months of receiving a term sheet.

Every point above the published benchmark adds friction in two places. First, the negotiation itself — each contested point extends the gap between lab result and incorporated company. Second, the cap table at the point of seed. A university stake of 17% at founding, before any angel or pre-seed dilution, leaves the founder with a cap table that is already tight before the institutional conversation that demands operational evidence has begun.

The Piece 1 argument in this series — that the funding system has shifted its question from "is this science good?" to "can this team operate a company?" — applies with particular force here, because the operational maturity demanded by programmes like Innovate UK's Velocity is precisely the kind of execution evidence that a software spinout's speed advantage should produce. The founders most affected by this gap are the founders most likely to build fast. That is the structural irony: the sector where speed matters most is the sector where the terms framework has converged least.

What the founding team controls

The terms argument is not won in policy. It is won in the board pack — and the founding team can start building that case now.

There are two responses to this data. Wait for TTO practice to catch up with TenU guidance — which it may, on the same two-to-three-year timeline life-sciences equity took. Or build the operational evidence that makes the case for different terms concrete rather than aspirational. The second response is the one the founding team controls.

Six months of consistent board packs, a rolling customer-discovery synthesis, a versioned financial model, and an IP register the TTO can read: these are not bureaucratic overhead. They are the single most legible signal a software founding team can present when the equity conversation begins. A founder who arrives with that substrate is not asking for lower equity on principle. They are demonstrating that value creation in this company is already happening in the execution layer — the layer the founders own — not in the founding IP.

The operational substrate described in Piece 3 of this series — named workflows with typed inputs and outputs, a structured knowledge layer, eval and observability, on-demand skills — is not only a survival tool for the seed window. It is the evidence base that converts a policy argument into a data argument.

The RAEng data on equity and outcomes suggests the investor market has already internalised this logic: lower-equity spinouts survive and exit at higher rates. The TTO market has not yet caught up for software specifically — but the data is now public for the conversation.

The gap the Venture Builder pilot does not fill

The first government-backed pre-formation programme targets the right stage but does not fund the operator.

Is there a programme that closes both problems at once — equity terms and operational capacity? Not yet. Innovate UK's Venture Builder pilot — up to £150,000 per project across three sectors (Frontier AI, Engineering Biology, Advanced Materials and Manufacturing) — sent EOI-stage outcome notifications in the first week of June 2026 (UKRI, Venture Builder Pilot). It is the first government-backed programme specifically targeting pre-company-formation deep-tech spinouts, and it names the right problem: the gap between research insight and incorporated company.

But the grant terms, as published, do not include a named operator-cost line. The £150,000 unit funds nine months of investability-building — governance frameworks, commercial strategy, financial modelling, the operational scaffolding that turns a research group into a company. If the founding team cannot hire or commission that capability within the grant terms, the nine months will produce technical milestones rather than the operational substrate the programme's own stated purpose implies.

For software spinouts in Frontier AI specifically, the constraint is double: equity terms that do not match the value-creation model, and a grant that does not fund the execution capacity needed to build the operational case for different terms. (Full programme details, eligibility rules, and the ICURe Exploit gate requirement are in the Evidence note.)

What the data now permits

A software founder with the RAEng report and the USIT for Software guide can name the gap in numbers, not frustration.

Before June 2026, the argument for lower software-spinout equity was policy guidance backed by VC preferences. After the RAEng Spotlight report, it is policy guidance backed by measured outcomes. The difference matters because TTO conversations are institutional conversations, and institutions respond to data more readily than to founder frustration.

A software founder entering a TTO equity negotiation in the second half of 2026 has three specific artefacts available: the TenU USIT for Software framework, co-authored by six leading TTOs, recommending 5–10% equity for software spinouts; the RAEng Spotlight on Spinouts 2026, showing the UK average at 16% and software-specific equity at approximately 17%; and the RAEng Enterprise Hub's equity-to-outcome analysis, showing that lower-equity spinouts survive and exit at higher rates.

Those three artefacts, combined with the founder's own operational evidence — the substrate, the board pack, the versioned model — constitute a case, not a complaint. The first conversation with the TTO is not "the terms should be lower." It is: "here is what TenU recommends, here is where the sector currently sits, here is what the outcome data shows, and here is the operational track record that demonstrates this company's value accretes in the execution layer."

Whether the TTO adjusts is a TTO decision. That the data now exists to make the case legibly is a structural change in the founding team's position. It happened in the first week of June 2026.

← Back to SpinUp Forge